Cart
sales@molnova.com
S26131
CAS No. 296280-56-3
S26131( N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide )
Catalog No. M26817 CAS No. 296280-56-3
S26131 behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | Get Quote |
|
| 5MG | 34 | Get Quote |
|
| 10MG | 56 | Get Quote |
|
| 25MG | 112 | Get Quote |
|
| 50MG | 166 | Get Quote |
|
| 100MG | 246 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameS26131
-
NoteResearch use only, not for human use.
-
Brief DescriptionS26131 behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively.
-
DescriptionS26131 behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively.(In Vitro):S26131 is an effective and selective antagonist of MT1 and MT2 with KBs of 5.32 and 143 nM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsN-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number296280-56-3
-
Formula Weight498.623
-
Molecular FormulaC31H34N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 31.25 mg/mL (62.67 mM)
-
SMILESCC(=O)NCCc1cccc2ccc(OCCCOc3ccc4cccc(CCNC(C)=O)c4c3)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li KJ, et al. Design, Synthesis, and Herbicidal Activity of Pyrimidine-Biphenyl Hybrids as Novel Acetohydroxyacid Synthase Inhibitors. J Agric Food Chem. 2018 Apr 18;66(15):3773-3782.
molnova catalog
related products
-
β-Glucosidase
β-Glucosidase is a glucoside bond hydrolase widely found in organisms and is involved in glucose metabolism, which can be used to study diseases caused by abnormal glucose metabolism.
-
CGGRGD TFA
CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).
-
Gastric Inhibitory P...
GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). GIP (1-30) amide, porcine is a weak inhibitor of gastric acid secretion and potent stimulator of insulin.
